Friday, November 15, 2024
HomeTagsSell FAP-2286

Sell FAP-2286

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286

Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe, and additional international markets, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics